Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).

ABSTRACT:

Background

Currently the World Health Organization only recommend fluoroquinolones for people with presumed drug-sensitive tuberculosis (TB) who cannot take standard first-line drugs. However, use of fluoroquinolones could shorten the length of treatment and improve other outcomes in these people. This review summarises the effects of fluoroquinolones in first-line regimens in people with presumed drug-sensitive TB.

Objectives

To assess fluoroquinolones as substitute or additional components in antituberculous drug regimens for drug-sensitive TB.

Search methods

We searched the Cochrane Infectious Diseases Group Specialized Register; CENTRAL (The Cochrane Library 2013, Issue 1); MEDLINE; EMBASE; LILACS; Science Citation Index; Databases of Russian Publications; and met

SUBMITTER: Ziganshina LE 

PROVIDER: S-EPMC6532730 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature